{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:47:32Z","timestamp":1773730052978,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.autrev.2020.102570","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T20:03:25Z","timestamp":1588536205000},"page":"102570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view"],"prefix":"10.1016","volume":"19","author":[{"given":"Andreas","family":"Kronbichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Eisenhut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keum Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.autrev.2020.102570_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"issue":"10229","key":"10.1016\/j.autrev.2020.102570_bb0010","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(20)30673-5","article-title":"WHO Strategic and Technical Advisory Group for infectious hazards. COVID-19: towards controlling of a pandemic","volume":"395","author":"Bedford","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.autrev.2020.102570_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"Mar 12","key":"10.1016\/j.autrev.2020.102570_bb0020","article-title":"Real estimates of mortality following COVID-19 infection","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10223","key":"10.1016\/j.autrev.2020.102570_bb0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10229","key":"10.1016\/j.autrev.2020.102570_bb0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102570_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"issue":"4","key":"10.1016\/j.autrev.2020.102570_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0050","first-page":"168","article-title":"Plasma soluble CD30 level correlates negatively with age in children","volume":"40","author":"Chen","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.autrev.2020.102570_bb0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exger.2016.10.001","article-title":"Associations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly","volume":"85","author":"Nadrowski","year":"2016","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.autrev.2020.102570_bb0060","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"20","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"issue":"4","key":"10.1016\/j.autrev.2020.102570_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5455\/aim.2008.16.219-225","article-title":"Evidence based medicine \u2013 new approaches and challenges","volume":"16","author":"Masic","year":"2008","journal-title":"Acta Inform Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0070","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/appi.ajp.162.3.578","article-title":"Comparison of large versus smaller randomized trials for mental health-related interventions","volume":"162","author":"Contopoulos-Ioannidis","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/annonc\/mdx819","article-title":"Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies","volume":"29","author":"Choi","year":"2018","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102570_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.autrev.2020.102570_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002049","article-title":"Why most clinical research is not useful","volume":"13","author":"Ioannidis","year":"2016","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses","volume":"94","author":"Ioannidis","year":"2016","journal-title":"Milbank Q"},{"issue":"11","key":"10.1016\/j.autrev.2020.102570_bb0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/bmjqs-2014-003114","article-title":"Learning from mistakes in clinical practice guidelines: The case of perioperative beta-blockade","volume":"23","author":"Neuman","year":"2014","journal-title":"BMJ Qual Saf. BMJ Qual Saf."},{"key":"10.1016\/j.autrev.2020.102570_bb0100","doi-asserted-by":"crossref","first-page":"f6426","DOI":"10.1136\/bmj.f6426","article-title":"\u201cFirst do no harm\u201d revisited","volume":"347","author":"Sokol","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/147323000403200205","article-title":"Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections","volume":"32","author":"Zakay-Rones","year":"2004","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.autrev.2020.102570_bb0110","first-page":"182","article-title":"Elderberry supplementation reduces cold duration and symptoms in air-Travellers: a randomized","volume":"8","author":"Tiralongo","year":"2016","journal-title":"Double-Blind Placebo-Controlled Clinical Trial Nutrients"},{"key":"10.1016\/j.autrev.2020.102570_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ctim.2018.12.004","article-title":"Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials","volume":"42","author":"Hawkins","year":"2019","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.autrev.2020.102570_bb0120","doi-asserted-by":"crossref","first-page":"l6202","DOI":"10.1136\/bmj.l6202","article-title":"The SSSPIN study-spin in studies of spin: meta-research analysis","volume":"367","author":"Bero","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.autrev.2020.102570_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/febs.15303","article-title":"Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?","author":"Olds","year":"2020","journal-title":"FEBS J"},{"issue":"7635","key":"10.1016\/j.autrev.2020.102570_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.39393.510347.BE","article-title":"Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review","volume":"336","author":"Jefferson","year":"2008","journal-title":"BMJ."},{"issue":"6485","key":"10.1016\/j.autrev.2020.102570_bb0135","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102570_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.autrev.2020.102570_bb0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40121-015-0091-9","article-title":"Rapid and effective virucidal activity of povidone-iodine products against middle east respiratory syndrome coronavirus (mers-cov) and modified vaccinia virus Ankara (mva)","volume":"4","author":"Eggers","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.autrev.2020.102570_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40121-018-0200-7","article-title":"In vitro bactericidal and virucidal efficacy of povidone-iodine gargle\/mouthwash against respiratory and oral tract pathogens","volume":"7","author":"Eggers","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000097758","article-title":"A clinical study on the tolerability of a liposomal povidone-iodine nasal spray: implications for further development","volume":"69","author":"Gluck","year":"2007","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2020.102570_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000246034","article-title":"The influence of long-term treatment with povidone-iodine on thyroid function","volume":"195","author":"Nobukuni","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2020.102570_bb0165","article-title":"Should I take elderberry supplements to ward off flu, coronavirus? Updated Mar 03, 2020","volume":"02","author":"Bamforth","year":"2020","journal-title":"Posted Mar"},{"issue":"6965","key":"10.1016\/j.autrev.2020.102570_bb0170","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.autrev.2020.102570_bb0180","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ng1698","article-title":"Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection","volume":"38","author":"Chan","year":"2006","journal-title":"Nat Genet"},{"issue":"30","key":"10.1016\/j.autrev.2020.102570_bb0190","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.2174\/1381612043382729","article-title":"Virus attachment and entry offer numerous targets for antiviral therapy","volume":"10","author":"Altmeyer","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2009.03.011","article-title":"Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions","volume":"83","author":"Auwerx","year":"2009","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632020701800101","article-title":"Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?","volume":"18","author":"Balzarini","year":"2007","journal-title":"Antivir Chem Chemother"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2007.03.003","article-title":"Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle","volume":"75","author":"Keyaerts","year":"2007","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.autrev.2020.102570_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.07.011","article-title":"Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin","volume":"133","author":"Millet","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010095","article-title":"Lectin digestibility and stability of elderberry antioxidants to heat treatment in vitro","volume":"22","author":"Jim\u00e9nez","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(98)00193-8","article-title":"Elderberry (Sambucus nigra) contains truncated Neu5Ac(alpha-2,6)Gal\/GalNAc-binding type 2 ribosome-inactivating proteins","volume":"425","author":"Peumans","year":"1998","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.autrev.2020.102570_bb0230","first-page":"290","article-title":"The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I","volume":"12","author":"Barak","year":"2001","journal-title":"Inflammatory cytokines Eur Cytokine Netw"},{"issue":"1","key":"10.1016\/j.autrev.2020.102570_bb0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/19390211.2013.859852","article-title":"An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration","volume":"11","author":"Ulbricht","year":"2014","journal-title":"J Diet Suppl"},{"issue":"10223","key":"10.1016\/j.autrev.2020.102570_bb0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.autrev.2020.102570_bb0245","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02503-16","article-title":"Structural characterization of human coronavirus NL63 N protein","volume":"91","author":"Szelazek","year":"2017","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102570_bb0250","first-page":"2006","article-title":"COVID-19 (novel coronavirus 2019) - recent trends","volume":"24","author":"Kannan","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.autrev.2020.102570_bb0255","first-page":"890","article-title":"A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it","volume":"44","author":"Hao","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.autrev.2020.102570_bb0260","author":"National Health Commission of the People'\u2019s Republic of China"},{"key":"10.1016\/j.autrev.2020.102570_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41392-020-0127-9","article-title":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2020.102570_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.autrev.2020.102570_bb0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the infectious diseases society of america: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102570_bb0285","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-ncov) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res"},{"issue":"9","key":"10.1016\/j.autrev.2020.102570_bb0290","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/CM9.0000000000000775","article-title":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.autrev.2020.102570_bb0295","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/infdis\/jit190","article-title":"Bacterial complications of respiratory tract viral illness: a comprehensive evaluation","volume":"208","author":"Falsey","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102570_bb0305","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and covid-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.autrev.2020.102570_bb0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"issue":"3","key":"10.1016\/j.autrev.2020.102570_bb0315","first-page":"185","article-title":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia","volume":"43","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.autrev.2020.102570_bb0320","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:56Z","timestamp":1761599876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220301324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1568997220301324"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102570","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102570"}}